Consensus holds that hematopoietic stem cells (HSCs) give rise to multipotent progenitors (MPPs) of reduced self-renewal potential and that MPPs eventually produce lineage-committed progenitor cells in a stepwise manner. Using a single-cell transplantation system and marker mice, we unexpectedly found myeloid-restricted progenitors with long-term repopulating activity (MyRPs), which are lineage-committed to megakaryocytes, megakaryocyte-erythroid cells, or common myeloid cells (MkRPs, MERPs, or CMRPs, respectively) in the phenotypically defined HSC compartment together with HSCs. Paired daughter cell assays combined with transplantation revealed that HSCs can give rise to HSCs via symmetric division or directly differentiate into MyRPs via asymmetric division (yielding HSC-MkRP or HSC-CMRP pairs). These myeloid bypass pathways could be essential for fast responses to ablation stress. Our results show that loss of self-renewal and stepwise progression through specific differentiation stages are not essential for lineage commitment of HSCs and suggest a revised model of hematopoietic differentiation.
INTRODUCTION
The hematopoietic system is maintained all through life by hematopoietic stem cells (HSCs) . Hierarchical relationships exist among HSCs, their progeny, and mature blood cells. Identification of functionally discrete populations in the hematopoietic system underlies hierarchical differentiation models (Akashi et al., 2000; Kondo et al., 1997; Nakorn et al., 2003) . In these models, multipotent self-renewing HSCs, mainly characterized by a CD150 
Flt3
À KSL) phenotype (Christensen and Weissman, 2001; Kiel et al., 2005; Morita et al., 2010; Morrison and Weissman, 1994; Osawa et al., 1996) , initially give rise to multipotent progenitors (MPPs) phenotypically defined as Flt3 (Adolfsson et al., 2005) . MPPs and LMPPs are considered to be multipotent progenitor cells with limited or no selfrenewal activity, that is, allowing only short-term (up to 8 weeks) multilineage repopulation. These multipotent progenitors generate lineage-committed progenitors such as common myeloid progenitors (CMPs) (Akashi et al., 2000) , common lymphoid progenitors (CLPs) (Kondo et al., 1997) , or megakaryocyte-erythroid progenitors (MEPs), with loss of self-renewal activity. Current models accept that HSC self-renewal capability is associated with multipotency and that HSCs lose differentiation potential in a stepwise manner in the process of blood maturation.
According to the present ''classical'' model, hierarchical differentiation proceeds with the first lineage commitment at the MPP stage, giving rise to all mature blood lineages. This model of a multipotent stem cell giving rise to a multipotent progenitor cell has been derived from the hematopoietic system and is commonly proposed as a blueprint for the hierarchy of other stem cell compartments. Despite wide acceptance of this concept, however, evidence from which hierarchical relationships are inferred is somewhat scanty and not definitive. Several recent studies have questioned this scheme of lineage commitment largely because LMPPs with both neutrophil-monocyte and lymphoid potentials, but little or no megakaryocyte-erythroid potential (MkE), have been detected (Adolfsson et al., 2005; Lai and Kondo, 2006; Yoshida et al., 2006) , suggesting that an alternative MkE differentiation pathway may exist. However, the issue of a branching point of MkE lineage remains controversial (Forsberg et al., 2006; Lai et al., 2005; Nutt et al., 2005) .
To analyze differentiation potentials of HSCs, simultaneous analysis of the differentiation capacity of individual cells is essential (Akashi et al., 2000; Benz et al., 2012; Dykstra et al., 2007; Kondo et al., 1997; Morita et al., 2010) . Conventional in vivo assays use the Ly5-congenic system to distinguish donor cells from recipient or competitor cells. Because the Ly5 antigen is expressed only on leukocytes, however, clonal and simultaneous analyses of lineage commitment of HSCs to five lineages, including erythrocytes and platelets, have not been reported: erythrocytes and platelets have always been excluded from evaluation for multilineage reconstitution. A transplantation system that can detect five mature blood lineages is required for accurate examination of differentiation potentials of HSCs and progenitor cells. Recently, we showed that CD150 high CD34
À KSL cells are enriched for myeloid-biased HSCs, which exhibit great self-renewal activity and predominant myeloid reconstitution (Morita et al., 2010) , and that this most primitive HSC compartment contains myeloid-restricted repopulating cells. These results suggested that a first lineage commitment toward myeloid lineage takes place at the level of HSCs.
To test this hypothesis, we first developed a transgenic mouse line in which not only T and B cells and neutrophils/monocytes but also erythrocytes and platelets are labeled by KusabiraOrange (KuO) fluorescent protein, enabling in vivo tracing of five lineages. Using single-cell transplantation of KuO-mouse bone marrow (BM) cells, we found, in the phenotypically defined HSC compartment, long-term repopulating cells with differentiation potential restricted to myeloid, megakaryocyteerythroid, or megakaryocyte lineages at a single-cell level (common myeloid repopulating progenitors [CMRPs], megakaryocyte-erythroid repopulating progenitors [MERPs] , and megakaryocyte repopulating progenitors [MkRPs] ), providing evidence for dissociation of self-renewal capacity from multipotency.
To examine whether HSCs directly differentiate into these myeloid-restricted repopulating progenitors (MyRPs), we employed a paired daughter cell (PDC) assay combined with single-cell transplantation. We were able to identify daughter cell pairs in which one was an HSC and the other was an MkRP as well as daughter cell pairs in which one was an HSC and the other was a CMRP, demonstrating that direct lineage commitment took place in an asymmetric manner at the HSC level and that HSCs can directly differentiate into lineage-restricted progenitors without passing through an MPP stage.
RESULTS

MyRPs Are Contained in the Phenotypically Defined HSC Compartment
To analyze all kinds of progeny clonally and simultaneously, we generated a transgenic mouse line in which Kusabira-Orange, encoding red fluorescent protein, is stably expressed in all blood cell lineages, including erythrocytes and platelets (KuO mice; Hamanaka et al., 2013) . This permitted five-lineage clonal tracing of donor-derived blood cells generated after single-cell transplantation, including neutrophils/monocytes (nm), erythrocytes (E), platelets (Plt), B cells (B), and T cells (T). CD150 + cells in the CD34 À KSL fraction have long-term and myeloid-biased repopulating activity (Kiel et al., 2005; Morita et al., 2010 Figure 1A ). We transplanted single cells from these three fractions into a total of 287 lethally irradiated C57BL/6-Ly5.2 (Ly5.2) mice, together with 2 3 10 5 competitor cells from C57BL/6-Ly5.1/Ly5.2-F1 (Ly5.1/Ly5.2-F1) mice, in four independent experiments ( Figure 1B ). Chimerism for donor-derived KuO + cells in nm, E, Plt, B, and T lineages in the peripheral blood (PB) of both primary and secondary recipient mice, as a percentage, was determined periodically ( Figure S1 available online). Our assay required new definitions, criteria, and terms. Recipient mice were regarded as reconstituted when at least one type of mature blood lineage contained donor-derived KuO + cells (0.1% or more) in PB at any time after transplantation. Of the 287 recipient mice, 28 died during follow-up after primary or secondary transplantations, and were eliminated from analyses. Of 259 mice, 130 (50.2%) were reconstituted with single fraction I, fraction II, or fraction III cells. Among the repopulating cells, we found three different types of multilineage repopulating cells. The multilineage repopulating cells were operationally classed as long-term HSCs (LT-HSCs), intermediate-term HSCs (ITHSCs), and short-term HSCs (ST-HSCs) according to the duration and level of multilineage reconstitution ( Figure 1C ). When all five types of mature blood cells in an individual mouse showed stable chimerism (0.1% or more) 20 weeks after secondary transplantation, the original single cell transplanted into the original recipient mouse (which was also, subsequently, a donor mouse for secondary transplantation) was retrospectively defined as an 2A, and S2A) . When five types of mature blood cells in an individual mouse showed chimerism (0.1% or more) 24 weeks after primary transplantation but at least one lineage disappeared in secondary recipient mice, the single cell transplanted into that individual mouse was defined as an IT-HSC ( Figures 1C, 2B , and S2B). IT-HSCs in this study may correspond to HSCs described by Benveniste et al. (Benveniste et al., 2010) . When, in a primary recipient mouse, mature blood cells of at least one lineage disappeared (that is, showed less than 0.1% chimerism) before 24 weeks after transplantation, the single cell transplanted into that mouse was defined as an ST-HSC ( Figures 1C, 2C , and S2C).
We were surprised to encounter in the phenotypically defined HSC compartment (fractions I, II, and III) progenitor cells functionally equivalent to CMPs, MEPs, and megakaryocyte progenitors (MkPs), but with repopulating activity at a single-cell level (CMRPs, MERPs, and MkRPs, respectively; Figures 1C, . CMRPs show nm, E, and Plt reconstitution but not lymphoid reconstitution (B and T lineages) . MERPs show only E and Plt reconstitution and MkRPs show only Plt reconstitution. Our description of these lineage-restricted progenitor cells with repopulating activity was enabled by single-cell Figure 3B ). In addition, Plt reconstitution was always detected first among the five blood lineages in recipient mice, including mice that had received single HSCs (Figures 2 and 3A , and data not shown). Plt chimerism also tended to decrease before that of cells in the other four blood lineages when HSC self-renewal finally ceased. These findings suggest a close relationship between HSCs and megakaryocyte lineages and that Plt reconstitution levels are good indicators of self-renewal potential. Figure S4A ). In four IT-HSC mice, KuO + hematopoietic cell populations were always detected except among fractions I/II cells and fraction III cells (Table 1 and Figure S4B ). Fractions I/II cells and fraction III cells were detected in one of four and two of four mice tested, respectively. On the other hand, in BM cells of ST-HSC mice (n = 4), we did not detect KuO + cells from fractions I/II and fraction III (Table 1 and Figure S4C ). In one of four ST-HSC mice, MPP and LMPP fraction cells were detected. Of importance is that in CMRP mice (n = 3), KuO + fraction III cells, LMPP fraction cells, (PB) was analyzed 2, 3, 4, 8, 16, and 24 weeks after primary transplantation (in addition, some mice were also analyzed at 12 weeks, some were also analyzed at 20 weeks, and some were also analyzed at 12 and 20 weeks). Secondary transplantation was performed by transferring 1 3 10 7 whole BM cells from primary recipient mice. PB chimerism was analyzed 4, 12, 16, and 20 weeks after secondary transplantation.
CMRPs and MkRPs Generated
(C) Definition of repopulating cell: When all five types of mature blood cells in an individual mouse showed stable chimerism (0.1% or more) 20 weeks after secondary transplantation, the original single cell was retrospectively defined as a long-term HSC (LT-HSC). When five types of mature blood cells in an individual mouse showed chimerism (0.1% or more) 24 weeks after primary transplantation but at least one lineage disappeared in secondary recipient mice, the original single cell was defined as an intermediate-term HSC (IT-HSC). When, in a primary recipient mouse, mature blood cells of at least one lineage disappeared (that is, showed less than 0.1% chimerism) before 24 weeks after transplantation, the original single cell was defined as a short-term HSC (ST-HSC). When only neutrophils/monocytes, erythrocytes, and platelets, but not cells of B and T lineages, were detected in mice, the original single cell was defined as a common myeloid repopulating progenitor (CMRP). When only erythrocytes and platelets were detected in mice, the original single cell was defined as a megakaryocyte-erythroid repopulating progenitor (MERP). When only platelets were detected in mice, the original single cell was defined as a megakaryocyte repopulating progenitor (MkRP). See also Figures S1 and S2. and CLPs, the fractions thought to tend to produce lymphoid lineages in BM cells, were never detected. KuO + fractions I/II cells were detected in BM of CMRP mice (n = 2) transplanted with single fraction I cells at 24 weeks after transplant ( Figure S4D ). However, in a CMRP mouse with a tendency toward decreasing chimerism, KuO + fractions I/II cells were not detected (n = 1, Figure S4E ).
These results indicated that HSCs with longer-term repopulating activity yield more primitive phenotypically defined HSCs in BM cells, suggesting that LT-HSCs are located upstream of IT-HSCs and ST-HSCs. Furthermore, these results strongly support the proposals that CMRPs and MkRPs have self-renewal activity with myeloid-restricted potentials and that they produce mature myeloid blood cells without passing through fraction III, LMPP, and CLP stages, suggesting that these BM cell fractions are not necessary for production of PB myeloid cells (nm, E, and Plt). . Four of nine recipient mice showed CMP-type reconstitution (mice 6-9) when ten MPPs were transplanted into mice ( Figure 4A ). However, repopulating activity was significantly diminished compared with that of CMRPs, MERPs, and MkRPs in the CD34 À KSL fraction ( Figure 2 and Figure 4A ). In contrast, when ten LMPPs were transplanted into mice, we did not detect CMP-type reconstitution ( Figure 4B ). Interestingly, the ten LMPP fraction cells yield a variety of cell types (nm, nmB, nmBT, nmEBT, nmEPltB, and nmEPltBT) and tend to produce nm and B lineages but not Plt. Figures S6A-S6E ). The results again indicated that these megakaryocyte progenitors are contained in fractions I/II but not in fraction III, suggesting that these progenitors are immediate progeny of HSCs.
To elucidate whether CMRPs, MERPs, and/or MkRPs directly arise from HSCs in vivo, we next performed PDC assays followed by single-cell transplants. PDC assays enable comparison of differentiation potentials of two daughter cells after one division of the mother cell (Suda et al., 1984; Takano et al., 2004) . This experimental system, with in vitro/in vivo clonal analysis, enables direct assessment of lineage commitment at the level of HSCs. Fraction I cells purified from KuO mouse BM cells were individually sorted into 96-well plates and cultured in the presence of SCF and TPO for 36-40 hr. As soon as they divided once, the resultant two daughter cells were separated by micromanipulation ( Figure 5A ). Individual daughter cells were transplanted into lethally irradiated Ly5.2 mice with 2 3 10 5 competitor cells from Ly5.1/Ly5.2-F1 mouse BM cells. Two hundred and four daughter cells in total (102 pairs) were successfully micromanipulated and transplanted into lethally irradiated Ly5.2 recipient mice. In 31 of 102 pairs, neither daughter cell reconstituted hematopoiesis in its recipient mouse. In 27 of 102 pairs, both daughter cells reconstituted hematopoiesis in their recipient mice. Among the 27 daughter cell pairs, we detected distinct patterns: One LT-HSC-LT-HSC pair (3.7%), 3 LT-HSC-IT/ST-HSC pairs (11.1%), 9 IT/ST-HSC-IT/ ST-HSC pairs (33.3%), 2 LT-HSC-MkRP pairs (7.4%), 3 ST-HSC-MkRP pairs (11.1%), 2 ST-HSC-CMRP pairs (7.4%), 3 CMRP-MkRP pairs (11.1%), 2 CMRP-CMRP pairs (7.4%), and 2 MkRP-MkRP pairs (7.4%; Figures 5B, 5C , and 5D, and Table  S1 ). Among 13 pairs yielded by symmetric division of HSCs, we detected 7 ST-HSC-ST-HSC pairs but only 1 LT-HSC-LT-HSC pair, despite the fact that self-renewal capability is strongest in fraction I. The daughter cells yielded solid, persistent five-lineage engraftment even in secondary recipients ( Figure 5B,  left) . We have reported such symmetrical self-renewal division in Lnk À/À HSCs in primary recipient mice (Seita et al., 2007) but, to our knowledge, this is the first definitive evidence for symmetrical self-renewal division of wild-type HSCs even in secondary recipient mice. Although these HSCs apparently are rare even among cells in the highly enriched HSC compartment, they may well be a good target for in vitro expansion.
To determine effects of short-term (36-40 hr) culture in this PDC assay on lymphoid and myeloid differentiation potentials, we compared reconstitution capabilities between freshly isolated fraction I cells and such cells after one division in vitro. No difference was appreciated in proportions of multipotent HSCs (including LT-, IT-and ST-HSCs), CMRPs, MERPs, and MkRPs between freshly isolated fraction I cells (representing mother cells) and fraction I cells allowed to divide once in short-term culture (representing daughter cells) (p > 0.1, Figure S6F) . Despite the fact that LT-HSCs have the highest repopulating capacity in vivo (Figure 2) , numbers of ST-HSCs but not of LT-HSCs were significantly increased in the PDC assay (p < 0.05). This is likely due to a limitation of the in vitro culture system employed. With even short-term culture in the PDC assay, a significant proportion of LT-HSCs turned into IT-and/or ST-HSCs ( Figure S6F ). Next, we compared differentiation potentials along each lineage (nm, E, Plt, B, and T) between the freshly isolated fraction I cells and singly divided fraction I cells ( Figure S6G ). Differentiation potentials were not significantly influenced by shortterm in vitro culture, indicating that the PDC assay itself did not alter differentiation. Thus, PDC assay combined with single-cell transplants can be regarded as a rational experimental method of assessing differentiation potentials of daughter cells in vivo.
The existence of LT-HSC-MkRP pairs, along with the prolonged repopulating activity of MkRPs compared with MPPs and LMPPs ( Figure 5C ), indicates that LT-HSCs can directly differentiate into long-term repopulation-competent MkRPs without passing through the intermediate stages of conventional functionally defined MPPs. This is an important demonstration that megakaryocyte lineage commitment can also occur at the HSC level through a distinct pathway (Figure 6 ). Of further interest is that we did not detect LT-HSC-CMRP pairs; instead, we found ST-HSC-CMRP pairs ( Figure 5D ), indicating that myeloid lineage commitment can occur at this level and does not need to go through the CMP-CLP separation stage. MkRPs were also produced from CMRPs via one division without passing through MEP status.
Discussion
Here we report myeloid-restricted progenitors with long-term repopulating activity and direct differentiation pathways from HSCs to these myeloid-restricted progenitors using five lineage .6%), CMRPs (n = 11, 13.3%), MERPs (n = 3, 3.6%), or MkRPs (n = 11, 13.3%). Single fraction II cells showed reconstitutive behavior of IT-HSCs (n = 3, 3.4%), ST-HSCs (n = 1, 1.1%), CMRPs (n = 19, 21.6%), MERPs (n = 2, 2.3%), MkRPs (n = 11, 12.5%), or ''other'' (n = 3, 3.4%). ''Other''-type reconstitution encompassed nmEPltB (nm, E, Plt, and B)-type (n = 1, 1.1%) and nmEPltT (nm, E, Plt, and T)-type (n = 2, 2.3%) reconstitution. Single fraction III cells exhibited reconstitutive behavior of IT-HSCs (n = 7, 8.0%), ST-HSCs (n = 25, 28.4%), CMRPs (n = 7, 8.0%), and others (n = 6, 6.8%). ''Other''-type reconstitution encompassed nmBTE (nm, E, B, and T)-type (n = 2, 2.3%), nmB (nm and B)-type (n = 2, 2.3%), and nmEPltB (nm, E, Plt and B)-type (n = 2, 2.3%) reconstitution. See also Figure S3 . Figure S4 .
tracing system. We studied reconstitution kinetics at 1-to 4-week intervals for up to 20-24 weeks in primary and secondary transplant recipients after transplantation of single KuO mouse hematopoietic stem/progenitor cells. To the best of our knowledge, this is the most vigorous and thorough experimental system in which to characterize hematopoietic stem/progenitor activities at the clonal level. Using this system, after examining 287 single HSC transplants, we were able to classify HSCs into three clearly defined groups (LT-HSCs, IT-HSCs, and STHSCs) according to reconstitution kinetics in primary and secondary transplant recipients. Both LT-and IT-HSCs fulfill current criteria for HSC status, viz., T, B and nm lineage reconstitution 4 months after transplantation, but LT-HSCs are more powerful, with multilineage reconstitution potential unchanged in both primary and secondary recipients. IT-and ST-HSCs, by contrast, lose their reconstitution activity in secondary or primary recipients. LT-HSCs are distinct in that donor chimerism never declines during a 20-24-week observation period in either primary or secondary recipients. Although at present LT-HSCs can be identified only in retrospect, they do represent ''true'' HSCs. Based on their reconstitution kinetics, LT-HSCs can be detected by measuring donor chimerism at 12 and 24 weeks after transplantation in the primary recipient and at 4 and 20 weeks after transplantation in the secondary recipient. These classifications, under our assay conditions in combination with PDC assays, permitted demonstration of symmetric self-renewal division of HSCs as an actual event, albeit a very rare one. Prospective isolation and molecular characterization of these three classes of HSCs may provide an opportunity to search for mechanisms of HSC self-renewal and expansion. We found that Plt was the first element to appear after transplantation of CD34 À KSL cells; indeed, in >96% of recipients that showed engraftment, early Plt reconstitution was observed. Interestingly, that thrombocytogenesis recovers earliest among these five forms of hematopoiesis is recognized in human BM and PB stem cell transplantation (Vellenga et al., 2001 ). On the other hand, Plt tended to decrease first among the five mature blood lineages as HSC activity deteriorated. The tight association between Plt lineage reconstitution and HSC activity after transplantation led us to think that a pathway may exist that preferentially produces myeloid cells, especially Plt. In this regard, Plt chimerism is an important parameter for detection of HSC activity. Myeloid cells (erythroid-and macrophage-like cells) reportedly emerge earlier in evolution (Hansen and Zapata, 1998) and also ontogenically develop earlier than lymphoid cells (Cumano and Godin, 2001 ). These observations may be related to our findings. In contrast to previous studies, we found lineage-restricted progenitor cells with long-term repopulating ability and differentiation potential restricted to megakaryocyte, megakaryocyte-erhtroid, or common myeloid lineages. Some of them manifested this lineage-restricted repopulating ability even in secondary recipients, excluding the possibility that lineage restrictions in repopulation resulted from niche factors. For example, even if niche factors are postulated that can direct commitment of a HSC only toward the megakaryocyte lineage, this HSC (or all HSCs generated from this HSC) must home to the same niche, one that directs the multipotent cell to generate progeny only along the megakaryocyte lineage, in secondary recipient BM. Otherwise, we should see generation of various lineage cells in secondary recipient mice. In addition, whereas multipotent HSCs were found in all three HSC subpopulations (fractions I-III), we detected MkRPs and MERPs only in fractions I and II but not in fraction III. Unless this putative Mk-or ME-directing niche affects only HSCs in fractions I and II, we should see generation of MkRPs and MERPs from all three fractions. Our data as an ensemble indicate that lineage-restricted repopulation is not a result of niche factors that direct differentiation of HSCs only toward certain lineage(s) and that lineage-restricted progenitor cells exist in the most primitive HSC compartment. Although the possibility that that lineage commitment resulted from niche factors cannot be totally excluded, we think that MkRP and MERP differentiation are regulated largely by cell-intrinsic factors.
Our PDC assay combined with single-cell transplantation allows us to assess differentiation potentials of daughter cells. Although TPO is known to have an instructive role in megakaryocytes, we have previously reported that megakaryocyte colony formation is not influenced by culturing CD34
À KSL cells with cytokine combinations in PDC assay such as SCF alone, SCF + IL-3, SCF + TPO, and SCF + IL-3 + TPO (Takano et al., 2004) . In fact, although both fraction I and III cells express TPO receptor, MkRPs were detected only in daughter cells of fraction I but not in fraction III (Table S1 and data not shown). We think that TPO does not have an instructive role on HSCs for commitment of cells in the HSC compartment toward megakaryocyte lineage. In PDC analyses, asymmetric self-renewal divisions producing HSC-MkRP, HSC-CMRP, or CMRP-MkRP combinations were found, clearly demonstrating a direct commitment of fraction I HSCs to lineage-restricted progenitors. Unexpectedly, we did not detect HSC-MERP pairs in this series of experiments, which probably is consonant with the low frequency of MERPs in fraction I (Figure 3 ). CMRPs were found more frequently than MERPs, yet we did not see an LT-HSC-CMRP pair upon PDC analysis. As shown in Figure S6F , short-term culture significantly decreases the frequency with which LT-HSCs are seen. We think that this is the principal reason why our PDC assay did not demonstrate LT-HSC-CMRP pairs. Alternatively, given that CMRPs are present not only in fractions I /II but also in fraction III in contrast to the exclusive distribution of MkRPs and MERPs in fractions I/II, CMRPs may be mainly generated from IT-HSCs and/or ST-HSCs but not from LT-HSCs. With respect to symmetric self-renewal divisions, we found HSC-HSC, CMRP-CMRP, and MkRP-MkRP combinations, which confirms these cell types' repopulating ability. Of further importance is that we did not detect any HSC-CLP or CMP-CLP daughter cell pairs in our assays. These data support the argument that HSCs preferentially produce particular myeloid progenitors, such as MkRPs and CMRPs, but not lymphoid progenitors. Highly purified HSCs are transcriptionally primed primarily along megakaryocyte-erythrocyte and neutrophil/ monocyte lines, but not lymphoid lines; lymphoid priming was instead observed in MPPs and LMPPs Må nsson et al., 2007; Ye et al., 2003) . Similarities in gene-expression pattern have been reported between HSCs and megakaryocytelineage cells (Huang and Cantor, 2009; Kent et al., 2009; Miyamoto et al., 2002) . These are compatible with our findings that MkRPs, MERPs, and CMRPs are close to HSCs in developmental pathways and that MkRPs and CMRPs are directly derived from HSCs. These data show that most primitive HSCs directly commit to lineage-restricted cells upstream of the MPP stage. In a series of single-cell experiments using freshly isolated fraction III cells, we found recipients reconstituted with nmB cells (Figure S3 ), but we never identified recipients reconstituted with nmBT and BT cells. In addition, single LMPPs reconstituted the nm lineage in 15 of 16 mice ( Figure S5 ). These data are compatible with the model proposed by Kawamoto et al. (2010) .
Of importance is that these MyRPs are not minor populations of cells. After single-cell transplantation of cells in the highly enriched HSC compartment (fraction I), among the 46 recipients that showed engraftment, 21 (45%) were engrafted by HSCs (multilineage reconstitution), 11 (24%) by MkRP cells, 11 (24%) by CMRP cells, and 3 (7%) by MERP cells. These newly identified repopulating progenitors thus represent nearly half the cells in the more primitive HSC compartment. In addition, they possess repopulating activity over 8 weeks at a single-cell level, whereas cells in the CD34 + KSL fraction that contained MPPs and LMPPs can reconstitute myeloid cells for no more than 8 weeks even after transplantation of 50 cells. Of great importance is that the ''MPP and LMPP'' fractions contain fewer multipotent cells than expected even when ten cells were transplanted (Figure 4) . In fact, single MPPs or LMPPs did not show ''real'' MPP-or LMPP-type reconstitution in 26 mice receiving single MPPs or in 48 mice receiving single LMPPs. These data indicate that cells in MPP and LMPP fraction are oligopotent progenitors (OPPs) rather than multipotent progenitors and suggest that MyRPs, rather than conventional ''MPPs and LMPPs,'' are the major suppliers of myeloid cells in the hematopoietic system ( Figure 6 ). Table S1 . See also Figure S6 . Together, MyRPs, rather than ''MPPs and LMPPs,'' are considered to be the major suppliers of myeloid cells (platelets, erythrocytes, and neutrophils/monocytes) in the hematopoietic system at a single-cell level. LMPP fraction yields cells with various differentiation potentials (B, nm, nmB, nmET, nmEB, nmEPlt, and nmEPltB) and these progenitors might derive from ST-HSCs in the CD34 Forsberg and her colleagues, in a recent study using a lineagetracing mouse model that elegantly enables direct assessment of differentiation pathways in vivo, concluded that hematopoietic lineage separation occurs downstream of Flt3 upregulation in LMPP fraction (Boyer et al., 2011) . Although this appears inconsistent with our results, Flt3 is likely expressed in cells at any point along the myeloid bypass differentiation pathways, and their lineage tracing system also detects cells developed through these pathways. Their conclusion holds; however, Flt3 expression is not exclusive to phenotypically defined LMPPs. Gilliland's group also suggested an alternative megakaryocyte differentiation pathway in KSL cells, based on analysis of gene-knockout mice (Cornejo et al., 2011; Mercher et al., 2008) . Their hypothesis of megakaryocyte differentiation is in harmony with our myeloid bypass model.
Our findings, viewed overall, permit us to propose a myeloid bypass differentiation pathway directly branching from the most primitive HSCs (Figure 6 ). In this model, lineage commitment takes place in a nonstepwise manner. The findings that myeloid-committed progenitors dominate the MPP fraction and that the LMPP fraction is heterogeneous suggest that the LMPP fraction might derive from ST-HSCs in the CD34 À KSL population but not from MPPs in the CD34 + KSL population in our previous study (Morita et al., 2010) . However, further studies are required to determine differentiation pathways to progenitors in the LMPP fraction. Furthermore, the question of whether MPPs really exist or not needs to be revisited. Our observations using single-cell transplantation and PDC assays clearly showed symmetric/asymmetric self-renewal divisions of HSCs and lineage commitment at the level of HSCs. In the current study, all the data were generated by transplantation into myeloablated hosts. That the stress of myeloablation influenced self-renewal and lineage commitment processes appears highly likely. To understand how these newly identified subsets of HSCs and repopulating progenitors behave under physiological conditions will require novel cell tracing systems or nonmyeloablative single-cell transplantation assay systems. Identification and characterization of differentiation pathways in hematopoiesis are essential to identify the key molecules for lineage commitment and to know how these regulators play a role in pathological hematopoiesis. Our work may enable further dissection of these processes and their mediators. In addition, our work permits us to propose this conceptual change: Loss of self-renewal activity in HSCs is not an essential step before commitment to progenitors. We believe that this concept is of critical importance not only for the field of hematopoiesis research but also for the field of stem cell research and for developmental biology in general.
EXPERIMENTAL PROCEDURES
Mice C57BL/6-Ly5.2 (Ly5.2) and C57BL/6-Ly5.1/5.2-F1 (Ly5.1/Ly5.2-F1) mice were purchased from Japan SLC (Shizuoka, Japan) and Sankyo-Lab Service (Tsukuba, Japan), respectively. Kusabira-Orange mice (KuO mice; Hamanaka et al., 2013) were backcrossed >7 times with C57BL/6-Ly5.1 mice. Nine-to twelve-week-old KuO mice served as donors and 8-to 11-week-old Ly5.2 mice served as recipients. Animal experiments were approved by the Animal Care and Use Committee, Institute of Medical Science, University of Tokyo.
Bone Marrow Hematopoietic Cell Sorting BM cells obtained from 9-to 12-week-old KuO mice were stained with APCconjugated anti-c-Kit (2B8, eBioscience, San Diego, CA) and c-Kit + cells
were enriched using anti-APC magnetic beads (Miltenyi Biotec, Auburn, CA) and LS columns (Miltenyi Biotec). These cells were then stained with Alexa Fluor 700-conjugated anti-CD34 (RAM34, eBioscience), Brilliant Violet 421-conjugated anti-CD150 (TC15-12F12.2, BioLegend, San Diego, CA), FITCconjugated anti-CD41 (MWReg30, eBioscience), PE-Cy7-conjugated antiSca-1 (D7, eBioscience) antibodies and with a lineage-marker cocktail of biotinylated anti-CD4 (RM4-5), -CD8 (53-6.7), -B220/CD45RA (Ly-5), -TER-119, -Gr-1 (Ly-6G/C), and -CD127 (IL-7Ra/A7R34) antibodies (all eBioscience), followed by staining with streptavidin-APC-Cy7 (BioLegend) to detect biotinylated antibodies. For MPP and LMPP sorting, BM cells isolated from KuO mice were stained with the antibodies listed above and with PerCP-eFluor 710-conjugated antiFlt3 antibody (A2F10, eBioscience).
For myeloid progenitor cell sorting, BM cells isolated from KuO mice were stained with a lineage-marker cocktail (biotinylated anti-CD4, -CD8, -B220/ CD45R, -Gr1, -TER-119, -CD127/IL7Ra, -CD3, and -CD19), Pacific Blue-conjugated anti-Sca-1 (D7, BioLegend), and streptavidin-APC-Cy7 after selection of c-Kit + cells.
Bone Marrow Transplantation
Cell were analyzed and sorted on a FACS Aria II cell sorter (special order system, BD Biosciences, San Jose, CA). For single-cell sorting, the presence of one cell per well was verified under an inverted microscope. Serial competitive reconstitution assays were performed. In brief, single cells from KuO mice mixed with 2 3 10 5 BM cells from Ly5.1/5.2-F1 mice were injected via tail vein into lethally irradiated Ly5.2 mice (4.9 Gy, each of two doses, 4 hr apart). Because no donor-derived cells were detected 1 week after transplant in mice transplanted with single CD34 À KSL cells, PB cells from recipient mice were analyzed 2, 3, 4, 8, 16, and 24 weeks after transplantation of CD34 À KSL cells (in addition, some mice were also analyzed at 12 weeks, some were also analyzed at 20 weeks, and some were also analyzed at 12 and 20 weeks). Secondary transplantation was performed by transferring 1 3 10 7 BM cells from femora and tibiae of the primary recipient mice into lethally irradiated Ly5.2 mice. PB cells from secondary recipient mice were analyzed 4, 12, 16, and 20 weeks after secondary transplantation. , 11, 14, 17, 20, 25, 34, 39, 53, 69, 84, 98, 115 , and 145 days after primary transplantation.
Paired Daughter Cell Assays
Single CD150 + CD41 À CD34 À KSL cells from BM of KuO mice were deposited into 96-well plates at one cell per well containing S-clone SF-O3 medium supplemented with 1% BSA, 50 ng/ml mSCF, 50 ng/ml mTPO, penicillin, streptomycin, L-glutamine, and 5 3 10 À5 M 2-mercaptoethanol. When a single mother cell underwent cell division and gave rise to two daughter cells, the resultant two daughter cells were separated by micromanipulation. We used a joystick micromanipulator MN-151 (Narishige, Tokyo, Japan), enabling three-dimensional fine movement of the micropipette. We also used a microinjector system IM-9B on a GJ-1 magnetic stand (Narishige). Upon the first division of an individual HSC, we aspirated one of the two daughter cells into a glass tube using the microinjector and transferred that cell into its own well. Each daughter cell was then transplanted into a lethally irradiated Ly5.2 mouse with 2 3 10 5 BM cells from Ly5.1/Ly5.2-F1 mice. PB cells from the recipient mice were analyzed 2, 3, 4, 8, 12, 16 , and 20 weeks after transplantations; PB of some recipient mice was also analyzed 9 days after transplantations. 
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